After Robert W. Baird and H.C. Wainwright gave Albireo Pharma (NASDAQ: ALBO) a Buy rating last month, the company received
Author: Christine Brown
Freshworks (FRSH) Receives a New Rating from a Top Analyst
Freshworks (FRSH – Research Report) received a Buy rating and a $50.00 price target from Oppenheimer analyst Brian Schwartz today.
Levi Strauss & Co (LEVI) Receives a Buy from Wells Fargo
Wells Fargo analyst Ike Boruchow maintained a Buy rating on Levi Strauss & Co (LEVI – Research Report) on October
Silverback Therapeutics (SBTX) Receives a Buy from Leerink Partners
In a report issued on October 14, Daina Graybosch from Leerink Partners maintained a Buy rating on Silverback Therapeutics (SBTX
Atara Biotherapeutics (ATRA) Gets a Buy Rating from William Blair
William Blair analyst Matt Phipps reiterated a Buy rating on Atara Biotherapeutics (ATRA – Research Report) on October 13. The
Analysts Are Neutral on Top Utilities Stocks: Hess Midstream Partners (HESM)
Analysts fell to the sidelines weighing in on and Hess Midstream Partners (HESM – Research Report) with neutral ratings, indicating
Analysts Offer Insights on Conglomerates Companies: and Deutsche Lufthansa AG (Other OTC: DLAKY)
Analysts are pulling back from the Conglomerates sector as 1 experts expressed today bearish sentiments on and Deutsche Lufthansa AG